NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
NADPH oxidase–derived excessive production of reactive oxygen species (ROS) in the kidney plays a key role in mediating renal injury in diabetes. Pathological changes in diabetes include mesangial expansion and accumulation of extracellular matrix (ECM) leading to glomerulosclerosis. There is a paucity of data about the role of the Nox5 isoform of NADPH oxidase in animal models of diabetic nephropathy since Nox5 is absent in the mouse genome. Thus, we examined the role of Nox5 in human diabetic nephropathy in human mesangial cells and in an inducible human Nox5 transgenic mouse exposed to streptozotocin-induced diabetes. In human kidney biopsies, Nox5 was identified to be expressed in glomeruli, which appeared to be increased in diabetes. Colocalization demonstrated Nox5 expression in mesangial cells. In vitro, silencing of Nox5 in human mesangial cells was associated with attenuation of the hyperglycemia and TGF-β1–induced enhanced ROS production, increased expression of profibrotic and proinflammatory mediators, and increased TRPC6, PKC-α, and PKC-β expression. In vivo, vascular smooth muscle cell/mesangial cell–specific overexpression of Nox5 in a mouse model of diabetic nephropathy showed enhanced glomerular ROS production, accelerated glomerulosclerosis, mesangial expansion, and ECM protein (collagen IV and fibronectin) accumulation as well as increased macrophage infiltration and expression of the proinflammatory chemokine MCP-1. Collectively, this study provides evidence of a role for Nox5 and its derived ROS in promoting progression of diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlation of mRNA and protein in complex biological samples
Maier, T., Güell, M., & Serrano, L. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.036 · Cited by 1,802 · cited 1×
“However, gene expression of Nox isoforms does not always correlate with protein levels and/or activity (53).”
BackgroundDiabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660 · cited 1×
“While Nox4 and to a lesser degree Nox2 have been shown to be mediators of diabetes-induced excessive ROS production in the kidney and have been linked to renal injury (8,9,22,23), little is known about the role of Nox5 in diabetic renal disease.”
BackgroundSelf-citationNADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386
Self-citationJha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352
Self-citationNovel Mechanism of Activation of NADPH Oxidase 5
Jagnandan, D., Church, J. E., Banfi, B., Stuehr, D. J., Marrero, M. B., & Fulton, D. J. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608966200 · Cited by 210 · cited 1×
“In addition, previous studies have shown that PKC mediates the phosphorylation of Nox5 (35,36).”
BackgroundDistinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180 · cited 1×
“Louis, MO) as previously described (18).”
Self-citationSERRANDER, L., JAQUET, V, BEDARD, K., PLASTRE, O., HARTLEY, O., ARNAUDEAU, S., DEMAUREX, N., SCHLEGEL, W., & KRAUSE, K. (2007) · Biochimie · doi:10.1016/j.biochi.2007.05.004 · Cited by 146 · cited 1×
“In addition, previous studies have shown that PKC mediates the phosphorylation of Nox5 (35,36).”
BackgroundTirone, F., Radu, L., Craescu, C. T., & Cox, J. A. (2010) · Biochemistry · doi:10.1021/bi901846y · Cited by 63 · cited 1×
“Since the Nox5 isoform contains four N-terminal Ca-binding EF-hand regulatory domains that serve to enhance the catalytic production of superoxide (50), it is possible that elevation of the intracellular Ca concentration may also activate Nox5 in renal cells, particularly in diabetes.”
BackgroundMolecular regulation of NADPH oxidase 5 via the MAPK pathway
Pandey, D., & Fulton, D. J. R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01163.2010 · Cited by 55 · cited 11×
“6C), PKC-a, and PKC-b in human mesangial cells (Fig.”
BackgroundInfluential
Cited by
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
“Similar findings were observed in mice expressing human Nox5 in a vascular smooth muscle cell-specific manner.(57) Although extensive experimental evidence showed a renoprotective effect of Nox4 inhibition in diabetes, a recent clinical study using GKT137831, a Nox1/4 inhibitor, failed to show improvement in renal fun…”
ResultSelf-citationNADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 534
Interrelation between ROS and Ca2+ in aging and age-related diseases
Madreiter-Sokolowski, C. T., Thomas, C., & Ristow, M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101678 · Cited by 365
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Warren, A. M., Knudsen, S. T., & Cooper, M. E. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1624721 · Cited by 245
“genic role for this isoform, but trials of its inhibition in humans are not yet underway [87].”
BackgroundSelf-citationHuang, D.-D., Shi, G., Jiang, Y., Yao, C., & Zhu, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109767 · Cited by 229
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Wang, N., & Zhang, C. (2024) · Antioxidants · doi:10.3390/antiox13040455 · Cited by 218
Jha, J. C., Ho, F., Dan, C., & Jandeleit-Dahm, K. (2018) · Clinical Science · doi:10.1042/cs20171459 · Cited by 205
Self-citationIncretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence
Alicic, R. Z., Cox, E. J., Neumiller, J. J., & Tuttle, K. R. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00367-2 · Cited by 193
Jha, R., Lopez-Trevino, S., Kankanamalage, H. R., & Jha, J. C. (2024) · Biomedicines · doi:10.3390/biomedicines12051098 · Cited by 144
“Among the many pathways implicated in ROS production, recent studies highlight the NOXs, particularly NOX4 and NOX5 as the most important contributors [12,28,29].”
BackgroundSelf-citation
Metadata
- Authors
- Jha, J. C., Banal, C., Okabe, J., Gray, S. P., Hettige, T., Chow, B. S. M., Thallas-Bonke, V., De Vos, L., Holterman, C. E., Coughlan, M. T., Power, D. A., Skene, A., Ekinci, E. I., Cooper, M. E., Touyz, R. M., Kennedy, C. R., & Jandeleit-Dahm, K.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2017-07-26
- Volume
- 66
- Issue
- 10
- Pages
- 2691-2703
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2738418450
- Cited by
- 142
- References
- 9
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.